Single and multiple oral doses of LGD-4665, a small molecule thrombopoietin receptor agonist, increase platelet counts in healthy male subjects

被引：8
|
作者：
Dziewanowska, Zofia E. [1 ]
Matsumoto, Richard M. [1 ]
Zhang, J. K. [1 ]
Schindler, Kristine [1 ]
Loewen, Gordon [1 ]
Doherty, James P. [2 ]
Berg, Jolene K. [2 ]
Newberry, Barbara [2 ]
机构：
[1] Clin Res Ligand Pharmaceut Inc, San Diego, CA USA
[2] CEDRA Clin Res, San Antonio, TX USA
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.1298.1298
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1298
引用
收藏
页码：390A / 390A
页数：1
相关论文
共 37 条
  • [21] SUVN-G3031: SAFETY, TOLERABILITY AND PHARMACOKINETICS OF A POTENT AND SELECTIVE HISTAMINE H3 RECEPTOR INVERSE AGONIST - SINGLE AND MULTIPLE ASCENDING DOSES IN HEALTHY SUBJECTS
    Nirogi, Ramakrishna
    Shinde, Anil
    Mudigonda, Koteshwara
    Bhyrapuneni, Gopinadh
    Muddana, Nageswara Rao
    Palacharla, Raghava Chowdary
    Ajjala, Devender Reddy
    Goyal, Vinod Kumar
    Ravula, Jyothsna
    Jetta, Satish
    Mohammed, Abdul Rasheed
    SLEEP, 2019, 42
  • [22] The safety, tolerability and pharmacokinetic profile of multiple doses of AD 452, a new once daily small molecule, broad spectrum anti-cytokine DMARD, in healthy male subjects.
    Mercer, A. J.
    Baker, H.
    Eltringham, E.
    Febbraro, S.
    Bakhtyari, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S36 - S36
  • [23] Tolerability, safety, pharmacokinetics and pharmacodynamics of SHR0534, a potent G protein-coupled receptor 40 (GPR40) agonist, at single- and multiple-ascending oral doses in healthy Chinese subjects
    Zhao, Yuqing
    Xie, Lijun
    Ou, Ning
    Wu, Jie
    Zhang, Hongwen
    Zhou, Sufeng
    Liu, Yun
    Chen, Juan
    Wang, Lu
    Wang, Libin
    Wang, Jingjing
    Shao, Feng
    XENOBIOTICA, 2021, 51 (03) : 297 - 306
  • [24] SAFETY, TOLERABILITY AND PHARMACOKINETICS OF A POTENT AND SELECTIVE HISTAMINE H3 RECEPTOR INVERSE AGONIST, SUVN-G3031 FOLLOWING SINGLE AND MULTIPLE ASCENDING DOSES IN HEALTHY SUBJECTS
    Nirogi, R.
    Mudigonda, K.
    Bhyrapuneni, G.
    Muddana, N. R.
    Palacharla, R. C.
    Ajjala, D. R.
    Goyal, V. K.
    Ravula, J.
    Jetta, S.
    Mohammed, A. R.
    Shinde, A.
    SLEEP MEDICINE, 2019, 64 : S281 - S281
  • [25] SUVN-G3031, A POTENT AND SELECTIVE HISTAMINE H3 RECEPTOR INVERSE AGONIST: SAFETY, TOLERABILITY AND PHARMACOKINETICS FOLLOWING SINGLE AND MULTIPLE ASCENDING DOSES IN HEALTHY ADULT SUBJECTS
    Bhyrapuneni, G.
    Goyal, V
    Pandey, S.
    Muddana, N.
    Palacharla, R.
    Ajjala, D.
    Ravula, J.
    Jetta, S.
    Badange, R.
    Benade, V
    Nirogi, R.
    SLEEP, 2020, 43 : A289 - A289
  • [26] SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF MULTIPLE ASCENDING ORAL DOSES OF ALG-055009, A THYROID HORMONE RECEPTOR BETA AGONIST, IN HYPERLIPIDAEMIC SUBJECTS AND RELATIVE BIOAVAILABILITY/FOOD EFFECT OF A SOLID FORMULATION IN HEALTHY VOLUNTEERS
    Charfi, Hakim
    Pinquier, Jean-Louis
    Le, Kha
    Wang, Stanley
    Kan-Eng, Ifong
    Westland, Christopher
    Gupta, Kusum
    Clark, Doug
    Mohammed, Naqvi
    Venkatraman, Meenakshi
    Blatt, Lawrence M.
    Beigelman, Leonid N.
    Lin, Tse-I
    Chanda, Sushmita
    McClure, Matthew
    HEPATOLOGY, 2024, 79 (02) : E84 - E85
  • [27] Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Novel Oral Small Molecule GLP-1 Receptor Agonist (HRS-7535) in Healthy Subjects -A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Dose Study
    Wu, Jingying
    Hu, Wei
    Du, Yijun
    Zhang, Qian
    Zhou, Renpeng
    Zhang, Qin
    Qin, Huiling
    Ye, Zi
    Xu, Yimei
    Feng, Sheng
    Shu, Chang
    Shen, Yu
    Fan, Yang
    DIABETES, 2023, 72
  • [28] Randomised clinical trial: safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple oral doses of tegoprazan (CJ-12420), a novel potassium-competitive acid blocker, in healthy male subjects
    Han, Sungpil
    Choi, Hee Youn
    Kim, Yo Han
    Nam, Ji Yeon
    Kim, Bongtae
    Song, Geun Seog
    Lim, Hyeong-Seok
    Bae, Kyun-Seop
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (07) : 751 - 759
  • [29] Safety, Tolerability, and Pharmacokinetic Evaluation of Single- and Multiple Doses of LY2979165, a Pro-Drug of an Orthosteric Metabotropic Glutamate 2 (mGlu2) Receptor Agonist in Healthy Subjects
    McColm, J.
    Swanson, S.
    Tauscher-Wisniewski, S.
    Foster, J.
    Suriyapperuma, S.
    Jackson, K.
    CURRENT NEUROPHARMACOLOGY, 2014, 12 : 40 - 40
  • [30] SAFETY, TOLERABILITY AND PHARMACOKINETICS OF SINGLE AND MULTIPLE ASCENDING DOSES OF THE EP2/EP3 RECEPTOR AGONIST ONO-8055, A POTENTIAL NEW THERAPY FOR UNDERACTIVE BLADDER, IN HEALTHY SUBJECTS
    Chapple, Christopher
    Bruce, Mark
    Ohno, Tomoya
    Kuwayama, Tomohiro
    Deacon, Stephen
    JOURNAL OF UROLOGY, 2015, 193 (04): : E235 - E235
1234